SCHEMBL20744975

SCHEMBL20744975

Nc1ncnc2c1cnn2C1CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.55
BTK Q06187 1/20 0.55
PI4KA P42356 2/20 0.54
PI4K2B Q8TCG2 2/20 0.54
PI4K2A Q9BTU6 2/20 0.54
PI4KB Q9UBF8 2/20 0.54
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 2/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
ADORA2A P29274 1/20 0.46
AKT1 P31749 4/20 0.46
AKT2 P31751 4/20 0.46
SIGMAR1 Q99720 1/20 0.46
XDH P47989 5/20 0.45
SRC P12931 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30041613 1.00 EGFR (0.55) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL19362509 0.93 EGFR (0.59) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL29617733 0.93 EGFR (0.59) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL21807058 0.93 EGFR (0.59) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL19463908 0.92 EGFR (0.58) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL31037237 0.92 EGFR (0.58) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL29886844 0.89 EGFR (0.50) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL1501671 0.89 EGFR (0.50) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL29887032 0.89 PI4KA (0.48) EGFRBTKPI4KAPI4K2BPI4K2A
SCHEMBL30563703 0.89 EGFR (0.50) EGFRBTKPI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668875-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2020-06-24 EP disclosed
WO-2019036001-A1 CDPK1 INHIBITORS, COMPOSITIONS, AND METHODS RELATED THERETO Vyera Pharmaceuticals, LLC (US) 2019-02-21 WO disclosed